Brief Report About the Role of Hyperthermic Intraperitoneal Chemotherapy in a Prospective Randomized Phase 3 Study in Recurrent Ovarian Cancer From Spiliotis et al.

Harter, Philipp; Reuss, Alexander; Sehouli, Jalid; Chiva, Luis; du Bois, Andreas

Harter, Philipp; Reuss, Alexander; Sehouli, Jalid; Chiva, Luis; du Bois, Andreas.

Afiliação

Harter P; *Department of Gynecology & Gynecologic Oncology, Kliniken Essen Mitte, Essen; Coordinating Center for Clinical Trials, Philipps-University Marburg, Marburg; Department of Gynecology, Charité, Berlin, Germany; and §Department of Gynecology Oncology, MD Anderson Cancer Center, Madrid, Spain.

Int J Gynecol Cancer ; 27(2): 246-247, 2017 02.

Article em En | MEDLINE | ID: mdl-28114231

ABSTRACT

ABSTRACT

A published so-called phase 3 study regarding HIPEC in ovarian cancer raised multiple questions. This commentary focusses on the weakness of the publication and discusses this in detail.

Assuntos

Carcinoma Epitelial do Ovário; Hipertermia Induzida; Neoplasias Ovarianas; Terapia Combinada; Procedimentos Cirúrgicos de Citorredução; Feminino; Humanos; Recidiva Local de Neoplasia; Estudos Prospectivos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Carcinoma Epitelial do Ovário / Hipertermia Induzida Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google